# Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

> **NCT00383422** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 320 (actual)

## Conditions studied

- Osteoporosis, Postmenopausal

## Interventions

- **DRUG:** Arzoxifene
- **DRUG:** Raloxifene

## Key facts

- **NCT ID:** NCT00383422
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2010-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00383422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00383422, "Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00383422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*